1-5 of 5
Sarath Kanekal
Close
Sort by
Journal Articles

Fetal Hemoglobin Induction in Baboons (P. Anubis) Following Admistration of a Novel Decitabine Dinucleotide (S110) Compound.

Donald Lavelle, PhD, Kestis Vaitkus, B.S., Virryan Banzon, M.S., Maria Hankewych, B.S., Pasit Phiasivongsva, Ph.D., Sanjeev Redkar, Ph.D., Sarath Kanekal, Ph.D., David Bearss, Ph.D., Chongtie Shi, Ph.D., Roger Inloes, Ph.D., Joseph DeSimone, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 571.
https://doi.org/10.1182/blood.V110.11.571.571
Published: 2007
Journal Articles

R-Etodolac and a Novel Indole-Pyran Structural Analog, SDX-308, Induce Cytotoxicity and Overcome Drug Resistance in Multiple Myeloma.

Hiroshi Yasui, Teru Hideshima, Paola Neri, Janice Jin, Tanyel Kiziltepe, Norihiko Shiraishi, Kenji Ishitsuka, Catley P. Laurence, Noopur Raje, Klaus Podar, Pierfrancesco Tassone, Dharminder Chauhan, Paul G. Richardson, Lorenzo M. Leoni, Sarath Kanekal, Gary T. Elliott, Nikhil C. Munshi, Kenneth C. Anderson
Journal: Blood
Blood (2005) 106 (11): 1580.
https://doi.org/10.1182/blood.V106.11.1580.1580
Published: 2005
Journal Articles

SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma

Hiroshi Yasui, Teru Hideshima, Makoto Hamasaki, Aldo M. Roccaro, Norihiko Shiraishi, Shaji Kumar, Pierfrancesco Tassone, Kenji Ishitsuka, Noopur Raje, Yu-Tzu Tai, Klaus Podar, Dharminder Chauhan, Lorenzo M. Leoni, Sarath Kanekal, Gary Elliott, Nikhil C. Munshi, Kenneth C. Anderson
Journal: Blood
Blood (2005) 106 (2): 706–712.
https://doi.org/10.1182/blood-2005-02-0838
Published: 2005
Journal Articles

SDX-101 Is Cytotoxic and Overcomes Drug Resistance in Multiple Myeloma.

Makoto Hamasaki, Teru Hideshima, Kenji Ishitsuka, Hiroshi Yasui, Norihiko Shiraishi, Shaji Kumar, Noopur Raje, Aldo M. Roccaro, Yu-Tzu Tai, Reshma Shiringarpure, Lorenzo Leoni, Sarath Kanekal, Gary Elliott, Nikhil C. Munshi, Kenneth C. Anderson
Journal: Blood
Blood (2004) 104 (11): 3466.
https://doi.org/10.1182/blood.V104.11.3466.3466
Published: 2004
Journal Articles

SDX-105 (Treanda™) Enhances the Tumor Growth Inhibitory Effect of Rituximab in Daudi Lymphoma Xenografts.

Sarath Kanekal, PhD, DABT, Brian Crain, Gary Elliott, PhD
Journal: Blood
Blood (2004) 104 (11): 4580.
https://doi.org/10.1182/blood.V104.11.4580.4580
Published: 2004